Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03549455 · ClinicalTrials.gov registry record · NA

Augmenting Exposure Therapy With Self-Distancing

A NA study, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT03549455 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 10 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03549455, a NA study, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

Anxiety is prevalent, impairing, and costly in childhood. Evidence-based treatments for pediatric anxiety exist; however, as many as 40-60% of youth do not demonstrate optimal response. By identifying psychological factors that potentiate symptom severity and treatment response, it may be possible to strengthen these factors to treat, or even prevent the development of youth emotional disorders. This study aims to examine whether the combination of Exposure and Self-Distancing is a feasible, acceptable, and efficient intervention for increasing perseverance in the face of exposures. This will be measured by child and parent report of treatment acceptability, examination of attendance and dropout rates, as well as participant and therapist report of participant engagement during exposures.

Interventions

  • BEHAVIORAL Exposure Therapy and Self Distancing

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2018-08-30
Est. Completion 2020-04-09
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT03549455

The ClinicalTrials.gov registry entry for NCT03549455 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Exposure Therapy and Self Distancing is the first listed.

NCT03549455 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03549455 about?

NCT03549455 is a clinical study titled "Augmenting Exposure Therapy With Self-Distancing". Anxiety is prevalent, impairing, and costly in childhood. Evidence-based treatments for pediatric anxiety exist; however, as many as 40-60% of youth do not demonstrate optimal response. By identifying psychological factors that potentiate symptom severity and treatment response, it may be possible t...

What is the current status of trial NCT03549455?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2018-08-30. Estimated completion is 2020-04-09.

What interventions are being tested in trial NCT03549455?

The interventions under investigation include: Exposure Therapy and Self Distancing (BEHAVIORAL).

Who is sponsoring clinical trial NCT03549455?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.